UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Identify the crucial factors when comparing indices, including coverage, weighting, and methodology. Use these pointers to sharpen your assessment.
16,969 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Citi upgrades Intuitive Surgical to Buy as market volatility eases, with Stryker placed on a 90-day catalyst watch an...
SPY trades near $668 amid rising oil to $100 and a higher VIX, yet retail traders on social forums stay bullish. The ...
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
A global energy crunch tied to the Iran war is renewing talk of a permanent four-day workweek. Experts say the shift ...
BlackRock’s chief executive argues that AI’s biggest impact is on who owns wealth, not just who loses a job. Here’s h...
Investors are recalibrating after airports report faster screening and shorter lines, sparking a mixed revaluation of...
A federal trade court has struck down a second round of tariffs ordered during the Trump administration. The decision...
Bank of America warns the Fed may be meaningfully deviating from most basic inflation-fighting rules, signaling a pot...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
With rate headlines dominating markets, experts say three actionable moves beat guessing games: automate saving, dive...